Havdala Ellen 4

What Happened
Havdala Ellen, a director of Ardent Health, Inc. (ARDT), was granted 14,231 restricted stock units (RSUs) on April 1, 2026 (transaction code A). The award shows an acquisition price of $0.00, indicating these are compensatory RSUs rather than a market purchase or sale. The units do not convert to actual shares until they vest.

Key Details

• Transaction date: 2026-04-01; filing date: 2026-04-02 (timely filing).
• Grant: 14,231 RSUs; acquisition price reported as $0.00.
• Vesting: RSUs vest in full on the first anniversary of April 1, 2026 (i.e., April 1, 2027), subject to continued service (per footnote).
• Shares owned after transaction: not disclosed in the provided filing.
• Transaction type/code: A = Award/Grant (restricted stock units).

Context
RSUs are a form of compensation that become actual shares (and typically taxable) only when they vest, so this grant does not represent an immediate sale or purchase in the open market. Director RSU grants are common as retention and alignment compensation; the filing is factual and does not imply any particular future performance.